Medicare Enrolled
Dr. Jeff Peterson, MD
Rheumatology · Bothell, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peterson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peterson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peterson
Dr. Jeff Peterson is a rheumatology specialist in Bothell, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Peterson performed 49,401 Medicare services across 825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peterson received a total of $2,373,737 from 55 pharmaceutical and/or device companies across 2493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peterson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in WA
$2,373,737 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,401
Medicare services
Top 8% in WA for rheumatology
825
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,470 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
26,352 | $11 | $49 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,725 | $34 | $94 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,690 | $25 | $169 |
| Denosumab injection (Prolia/Xgeva) | 3,480 | $18 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $90 | $353 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
509 | $100 | $403 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
499 | $1 | $6 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
167 | $22 | $82 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
120 | $1 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
76 | $131 | $461 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $10 | $56 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
46 | $45 | $142 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $128 | $588 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $60 | $244 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
32 | $54 | $209 |
| New patient office visit, complex (60-74 min) | 32 | $173 | $760 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
90.6% high complexity
7.9% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,373,737
Total received (2018-2024)
Avg $339,105/year across 7 years
Top 0% in WA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
2,493
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$1,120,229 (47.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,098,631 (46.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$137,983 (5.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,895 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$145,159
2023
$196,591
2022
$1,176,536
2021
$205,565
2020
$161,743
2019
$295,180
2018
$192,963
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$85,370
Lilly USA, LLC
$22,144
Janssen Biotech, Inc.
$13,378
UCB, Inc.
$10,654
SOBI, INC
$5,102
ABBVIE INC.
$4,149
Novartis Pharmaceuticals Corporation
$1,592
GENZYME CORPORATION
$1,308
AstraZeneca Pharmaceuticals LP
$444
GlaxoSmithKline, LLC.
$426
Aurinia Pharma U.S., Inc.
$137
Genentech USA, Inc.
$99
Alexion Pharmaceuticals, Inc.
$90
ANI Pharmaceuticals, Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Kiniksa Pharmaceuticals International, plc
$33
Radius Health, Inc.
$32
Mallinckrodt Hospital Products Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Top 3 companies account for 83.3% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$1,712,805
Lilly USA, LLC
$305,338
Amgen Inc.
$89,300
Horizon Pharma plc
$74,384
Novartis Pharmaceuticals Corporation
$49,873
UCB, Inc.
$23,245
Janssen Biotech, Inc.
$20,294
United Rheumatology
$17,500
Mallinckrodt LLC
$14,035
GlaxoSmithKline, LLC.
$13,247
AbbVie, Inc.
$12,342
GENZYME CORPORATION
$9,409
ABBVIE INC.
$6,213
Regeneron Pharmaceuticals, Inc.
$6,084
SOBI, INC
$5,404
Sobi, Inc
$1,775
Janssen Global Services, LLC
$1,500
Alexion Pharmaceuticals, Inc.
$1,388
Celgene Corporation
$1,323
AstraZeneca Pharmaceuticals LP
$956
Regeneron Healthcare Solutions, Inc.
$887
E.R. Squibb & Sons, L.L.C.
$883
PFIZER INC.
$721
AbbVie Inc.
$635
NOVARTIS PHARMACEUTICALS CORPORATION
$575
Genentech USA, Inc.
$459
Radius Health, Inc.
$456
Takeda Pharmaceuticals U.S.A., Inc.
$449
Eli Lilly and Company
$332
Aurinia Pharma U.S., Inc.
$296
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
UCB Biosciences Inc.
$235
Genentech, Inc.
$232
Bausch & Lomb Americas Inc.
$180
Hikma Pharmaceuticals USA
$88
Mallinckrodt Enterprises LLC
$84
ANI Pharmaceuticals, Inc.
$82
Mallinckrodt Hospital Products Inc.
$60
West-Ward Pharmaceuticals
$54
Janssen Scientific Affairs, LLC
$46
Novo Nordisk Inc
$40
Bioventus LLC
$35
Kiniksa Pharmaceuticals International, plc
$33
Janssen Pharmaceuticals, Inc
$28
Sandoz Inc.
$24
Ultragenyx Pharmaceutical Inc.
$22
Kyowa Kirin, Inc.
$20
Alfasigma USA, Inc.
$19
Gilead Sciences, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Amarin Pharma Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$13
Sentynl Therapeutics, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 88.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMJEVITA · AVSOLA · Actemra · Aimovig · Arcalyst · BENLYSTA · Bimzelx · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUPIXENT DUPILUMAB INJECTION · Durolane · EVENITY · Edarbi · Enbrel · FORTEO · GAMIFANT · HUMIRA · HYRIMOZ · Humira · ILARIS · INFLECTRA · INVOKANA · Ilumya · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Levorphanol Tartrate · Mitigare · NO PRODUCT DISCUSSED · NO_PRODUCT · NUCALA · OLUMIANT · ORENCIA · Otezla · Ozempic · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · REYVOW · RINVOQ · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNAGIS · Strensiq · Synagis · TALTZ · TAVNEOS · TEPEZZA · TEZSPIRE · TORIC · TREMFYA · Tavneos · Tymlos · Uloric · Vascepa · Victoza · XELJANZ · enVista MX60 IOL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 0% for rheumatology in WA.
Geographic Context
Rheumatologists within 10 mi
99
Per 100K population
11.9
County median income
$107,982
Nearest hospital
EVERGREENHEALTH MEDICAL CENTER
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peterson is a mixed practice specialist, with above-average Medicare volume (top 8% in WA), with mixed engagement industry engagement in the top 0% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peterson experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Peterson performed 26,352 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peterson receive payments from pharmaceutical companies?
Yes. Dr. Peterson received a total of $2,373,737 from 55 companies across 2,493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peterson's costs compare to other rheumatologists in Bothell?
Dr. Peterson's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peterson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Bothell
Browse rheumatologists in Bothell ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in WA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in WA
Which WA rheumatologists receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology